DEXAMETHASONE 5 MG/ML SOLUTION

País: Canadá

Língua: inglês

Origem: Health Canada

Ingredientes ativos:

DEXAMETHASONE SODIUM PHOSPHATE

Disponível em:

ALBERTA VETERINARY LABORATORIES LTD

Dosagem:

5MG

Forma farmacêutica:

SOLUTION

Composição:

DEXAMETHASONE SODIUM PHOSPHATE 5MG

Via de administração:

INTRAMUSCULAR

Unidades em pacote:

100ML

Tipo de prescrição:

OTC

Grupo terapêutico:

CATTLE; CATTLE; CATTLE; HORSES; CATS; DOGS

Resumo do produto:

Active ingredient group (AIG) number: 0131220002

Status de autorização:

APPROVED

Data de autorização:

2018-05-16

Folheto informativo - Bula

160 mm
65 mm
Dexamethasone 5 mg/mL 100mL Bottle Label Mock-Up
Label Size:
160mm x 65mm Rectangle
Colours:
Black and white only, no graphics
Font Style:
Arial; Arial Narrow
Font Sizes:
Product name - 11
Proper name - 6
DIN & Sterile - 7
Warning and Manufacturer Address - 6
Volume - 10
Expiry - 8
English and French Panel Text - 4.5
Date of Preparation
April 24 2018
DEXAMETHASONE 5 MG/ML
Dexamethasone Injection, USP 5 mg/mL
Injection de dexaméthasone, USP 5 mg/mL.
STERILE/ STÉRILE | DIN XXXXXXXX
Veterinary Use Only/ Usage Vétérinaire Seulement
WARNINGS: KEEP OUT OF REACH OF CHILDREN. THIS
DRUG IS NOT TO BE ADMINISTERED TO HORSES THAT
ARE TO BE SLAUGHTERED FOR USE IN FOOD. NO
WITHDRAWAL PERIOD FOR MEAT AND WITHHOLDING
TIME FOR MILK ARE REQUIRED WHEN USED ACCORDING
TO THE LABEL.
MISES EN GARDE : GARDER HORS DE PORTÉE DES
ENFANTS. CE MÉDICAMENT NE DOIT PAS ÊTRE
ADMINISTRÉ AUX CHEVAUX DEVANT ÊTRE ABATTUS À
DES FINS ALIMENTAIRES. UN DÉLAI D’ATTENTE N’EST
PAS REQUIS POUR VIANDE ET UNE PÉRIODE DE RETRAIT
POUR LE LAIT QUAND LES DIRECTIVES DE L’ÉTIQUETTE
SONT SUIVIES.
ALBERTA VETERINARY LABORATORIES LTD.
411 – 19th Street SE, Calgary, AB T2E 6J7
100 ML
Lot: XXXXXXXX
EXP: MMYY
ACTIVE INGREDIENTS : Each mL contains: Dexamethasone sodium phosphate
5 mg
Preservatives (per mL): Methylparaben 1mg Propylparaben 0.1 mg
INDICATIONS: Dexamethasone 5 mg/mL is indicated as an aid in the
treatment of bovine
ketosis and as an anti-inflammatory agent in dogs, cats, cattle and
horses. Small animal
indications include inflammatory conditions involving the joints
(where structural changes such
as ankylosing joints, ruptured ligaments, sheaths, etc. do not exist)
and nonspecific dermatitis.
Equine indications include bursitis, carpitis, osselets, tendinitis,
myositis, sprains and as
supportive therapy in fatigue, heat exhaustion and acute infectious
diseases. If bony changes
exist in any of these conditions, a response to Dexamethasone 5 mg/mL
cannot be expected.
DOSAGE AND ADMINISTRATION: Therapy with Dexamethasone 5 mg/m